Clinical Trial Update: Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluating a combination of cetuximab, paclitaxel, carboplatin, and radiation therapy in patients with unresectable stage IIIA or IIIB…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Paraplatin (Carboplatin)
• Radiation therapy
• Taxol (paclitaxel)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED